Study Shows Pitavastatin Can Prevent Cancer Development in Cases of Chronic Inflammation
Discover how the drug pitavastatin can effectively prevent cancer development in cases of chronic inflammation by blocking interleukin 33 (IL-33) expression. The study reveals the role of IL-33 in cancer-prone chronic inflammation and the ability of pitavastatin to inhibit IL-33 expression through the mevalonate pathway. Learn how this research highlights the potential of statins, like pitavastatin, as a safe and effective strategy for preventing cancer-related consequences of chronic inflammation.
The Legacy of Richard ‘Rick’ Slayman: First Man to Receive Pig Kidney Transplant
Discover the groundbreaking story of Richard ‘Rick’ Slayman, the first man to undergo a genetically modified pig kidney transplant. Despite his passing, his journey offers hope and inspiration for the future of xenotransplantation and the potential of genetically modified animals in organ transplants.
Man Discharged After Receiving Genetically Modified Pig Kidney Transplant
The first man to receive a genetically modified pig kidney transplant has been discharged from Massachusetts General Hospital after a successful surgery. The historic procedure is being celebrated as a significant milestone in the field of transplantation, offering hope to thousands of people in need of transplants. The pig kidney, modified by eGenesis, was approved for use under a compassionate use protocol, potentially addressing the world’s organ shortage.
Man recovering well after receiving genetically modified pig kidney
62-year-old Rick Slayman received a genetically modified pig kidney in a pioneering transplant surgery, marking a major milestone in organ availability. With a chronic shortage of human donor organs, animal donors may provide hope for thousands in need of transplants. The special pig kidney was provided by eGenesis of Cambridge, Massachusetts, and Mr. Slayman’s recovery is being closely monitored as he continues to take anti-rejection drugs.